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Background: Gallstones (GS) are formed as a result of impaired metabolic regulation of the human body.
Abnormal lipid metabolism is partly responsible for the pathogenesis of GS mainly rich in cholesterol. Thus
abnormalities of serum lipids would reflect the possibilities of the formation of cholesterol GS. This study aims
to identify the significance of serum lipids on the development of GS disease.
Methods: Serum lipid profiles were estimated in 73 patients with symptomatic GS, admitted to the Teaching
Hospital, Peradeniya, Sri Lanka for GS removal surgeries from May 2011 to December 2012. Patients with normal
serum bilirubin level and not being on lipid lowering drugs were recruited for the study. Serum lipid profile of
each patient was analyzed by enzymatic kit assays and the chemical composition of GS was analyzed by Fourier
Transform Infrared spectroscopy.
Results: Of the 73 patients, 37 (51%) had cholesterol GS while 36 (49%) had pigment GS. Serum lipid parameters
of a majority of patients were within the normal range. Body mass index values of the patients with two types of
GS were not significantly different (Two sample t test, p = 0.335). Out of the lipid parameters tested, only serum
triglyceride concentration was significantly high in patients with cholesterol GS than that of pigment GS (Two
sample t test, p = 0.038). None of the lipid parameters were significantly different between males and females
(Two sample t test, p > 0.05). Compared to the patients with pigment GS who were aged below 50 years, mean
total cholesterol and triglyceride concentrations were higher in the same age category patients with cholesterol GS.
Conclusion: Abnormal serum lipid profiles doesn’t seem to be an essential feature in patients with cholesterol GS.
However when the two groups of patients with cholesterol and pigment GS with no significant difference of body
mass indexes were compared, patients with cholesterol GS are more likely to have serum lipid parameters towards
the undesirable cutoff levels of their respective normal ranges. However an effect of serum lipid concentrations on
high incidence of GS among females has not been identified.
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Gallstones (GS) are formed in the gall bladder and biliary
tract and are of two types: namely cholesterol and pigment
stones [1]. GS is one of the main causes for number of
upper gastrointestinal surgical casualties [2]. Despite the
wider exploration into the aetiopathogenesis of GS, know-
ledge on exact pathogenesis of GS is yet incomplete.* Correspondence: harshitw83@yahoo.com
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article, unless otherwise stated.Complex interaction of multiple environmental risk
factors with the genetic risk factor is the most possible
explanation given for this incomplete understanding.
Biliary cholesterol supersaturation is identified as a
main prerequisite for the formation of cholesterol GS
[3] and elevated unconjugated bilirubin in bile is consid-
ered as the primary cause for the pigment GS [4]. Thus
GS are formed as a result of impaired metabolic regulation
of human body. Biliary cholesterol hypersecretion is the
main cause for biliary cholesterol supersaturation and bile
stasis also plays an additional role [5]. Impaired lipid
homeostasis can give rise to cholesterol hypersecretiontral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Age and gender distribution of patients with two
types of GS
Physical parameter Cholesterol GS Pigment GS P value
Age (mean ± SD) years 41.1 ± 9.2 48.5 ± 10.3 0.002*
Gender (n,%)
Females 34 (57%) 26 (43%) 0.035$
Males 03 (23%) 10 (77%)
*-Two sample t test.
$-Fisher’s exact test.
Table 2 Undesirable lipid parameters in patients with
cholesterol and pigment GS
Serum lipid parameter No of patients in undesirable level
Cholesterol GS n (%) Pigment GS n (%)
TC 07 (19) 03 (08)
TG 05 (14) 03 (08)
HDL-C 00 (00) 03 (08)
LDL-C 07 (19) 12 (33)
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lesterol GS compared to pigment GS can be expected in
patients with impaired lipid homeostasis.
Even though a positive correlation between serum
triglycerides (TG) and nucleation time of cholesterol in
bile is identified, a relationship between serum lipids and
biliary cholesterol saturation index has not been identified
[6]. Moreover, controversial results have been obtained for
the serum lipid profiles of patients with GS. In some
case control studies, serum hypertriglyceridemia and
low HDL-cholesterol (HDL-C) have shown a significant
association with GS disease [7-9]. However it has not been
a common observation [10].
If impaired lipid homeostasis is the main cause for
cholesterol supersaturation and crystallization, a signifi-
cant difference between serum lipid profiles of patients
with cholesterol and pigment GS should be observed, as
cholesterol hypersecretion is not a recognized cause for
the pathogenesis of pigment stones. Therefore compa-
rison of lipid profiles in patients with two types of GS
would be important in detecting the significance of
different lipid parameters on the development of com-
positionally different GS. Moreover serum lipids might
have an effect on the high incidence of GS disease
among females [11] and on the age related changes in
the chemical composition of GS [12]. The objective of
this study was to identify the relationship between serum
lipids and the pathogenesis of different types of GS.
Methods
The study was carried out during May 2011 to December
2012 in a cohort of patients with symptomatic GS,
admitted to Teaching hospital, Peradeniya, Sri Lanka
for surgical removal of GS. Inclusion criteria for the study
were, age more than 18 years, residing in Kandy district,
Sri Lanka for more than five years, normal total bilirubin
concentration [13] and not being on lipid lowering drugs.
Informed written consent was taken from the patients at
the time of recruitment. An interviewer administered
formatted data sheet which included age, gender, comor-
bidities and drug history of the patient was used in data
collection. Weight and height of each patient was mea-
sured using standard techniques [14] to calculate the body
mass index (BMI). According to BMI values, patients were
classified into two groups as normal and overweight or
obese based on the WHO BMI cutoff values [15]. A sam-
ple of 2 ml venous blood was taken from each patient after
a fasting period of 12 hours [16]. Serum samples were
stored at −20°C and the lipid profiles were analyzed within
4 weeks of sample collection. Total Cholesterol (TC),
TG and HDL- C in serum were analyzed by enzymatic
methods using enzyme assay kits purchased from Aggape
Diagnostics, Germany. All the tests were done in du-
plicates and mean value was taken as the end result.Measurements of the standard samples were taken at
the beginning, middle and end of the test samples to
improve the accuracy of the readings. LDL- cholesterol
(LDL-C) was calculated using Friedewald equation [17].
Gallstones removed at the time of surgery were pre-
served appropriately and the chemical composition was
identified by the physical characteristics and Fourier
Transform Infrared spectroscopy (FTIR, Shimadzu IR
prestige 21). Previously described methods were used in
the analysis of chemical composition of the GS by FTIR
[18,19]. GS were divided in to two groups as, cholesterol
and pigment GS, based on the chemical composition [1]
and the lipid profile results of the two groups were
compared in the final analysis. In addition, serum
lipid profiles of patients with the two types of GS
were compared after categorizing them in to two age
groups each as 50 years or less and above 50 years. This
was done based on the median age of menopause of
Sinhalese females [20].
Data obtained were analyzed by Minitab 14 software
in which two sample t test was used to analyze the con-
tinuous data, while chi square and Fisher’s exact tests
were used in the analysis of categorical data.
The cutoff values used to determine the desirable
levels of serum lipids were; serum TC below 200 mg/dl,
TG below 150 mg/dl, HDL-C above 40 mg/dl and LDL-C
below 100 mg/dl [21]. Ethical clearance for the study was
obtained from the Ethical Review Committee, Faculty of
Medicine, University of Peradeniya, Sri Lanka.
Results
A total of 73 patients were recruited to the study, based
on the inclusion criteria. Mean age of the total study
group was 44.6 ± 10.4 years and majority was females.
Table 3 Comparison of serum lipids in patients with cholesterol and pigment GS
Serum lipid parameter (mg/dl) Cholesterol GS (n = 37) Mean ± SD Pigment GS (n = 36) Mean ± SD P value*
TC 172.0 ± 30.1 167.8 ± 25.1 0.515
TG 155. 0 ± 20.9 143.00 ± 27.1 0.038
HDL-C 54.05 ± 9.19 51.5 ± 10.0 0.261
LDL-C 86.9 ± 33.0 88.5 ± 29.0 0.826
*Two sample t test.
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44.0 ± 10.4 and 47.1 ± 10.0 years respectively. A greater
proportion (n = 52, 71%) of patients in the study group
were aged 50 years or less.
Of the total, 37 (51%) had cholesterol GS while 36
(49%) had pigment GS. Age and gender distribution of
patients with two types of GS are shown in Table 1. Mean
age of the patients with cholesterol GS was 41.1 ± 9.2 years
and those with pigment GS was 48.5 ± 10.3 years, denot-
ing a significant difference (Two sample t test, p = 0.002).
Among the 60 females, majority (n = 34, 57%) had chol-
esterol GS, while majority of males (n = 10, 77%) had
pigment GS. Compared to males the cholesterol GS were
common among females (Fisher’s exact test, p = 0.035).
In the group of patients aged ≤ 50 years, majority (n = 31,
60%) had cholesterol stones whereas majority (n = 15, 71%)
of patients aged > 50 years had pigment stones. Fre-
quency of detecting cholesterol GS among the patients
aged ≤50 years was significantly common compared to
that of patients aged > 50 years (Chi square test, p = 0.010).
Mean BMI of the patients with cholesterol GS (26.06 ±
3.15 kg/m2) was not statistically significant (Two sample
t test, p = 0.335) from that of the patients with pigment
GS (25.28 ± 3.28 kg/m2). Mean concentrations of serum
total cholesterol, TG, HDL-C and LDL-C in the total
study group were 169.9 ± 27.6, 149.1 ± 24.7, 52.9 ± 9.6
and 87.2 ± 30.7 mg/dl respectively.
Even though none of the patients in this study cohort
had a history of dyslipidemia few had serum lipid para-
meters in undesirable range (Table 2). Serum lipid con-
centrations in patients with cholesterol and pigment GS
are shown in Table 3. In the comparison of serum lipids
among patients with two types of GS, serum TG, TC and
HDL-C were higher in patients with cholesterol GS than
pigment GS. However a statistical significance was seen
only for serum TG (Two sample t test, p = 0.038).Table 4 Comparison of serum lipids in females and males in t
Serum lipid parameter (mg/dl) Females (n =60) Mean ±
TC 171.1 ± 28.8
TG 149.4 ± 23.8
HDL-C 53.82 ± 8.39
LDL-C 87.8 ± 32.0
*Two sample t test.Serum lipids among male and female patients are shown
in Table 4. None of the serum lipid parameter was signi-
ficantly different between females and males (Two sample
t test, P > 0.05).
Serum lipid profiles in patients with two types of gall-
stones were further analyzed after categorizing them
into two age groups as age ≤ 50 years and > 50 years and
are summarized in Tables 5 and 6. Irrespective of the
age category high serum TC and TG were seen among
the patients with cholesterol GS. However none of these
parameters were significantly different (Two sample t test,
p > 0.05) in both age categories.
Discussion
This study describes the pattern of serum lipid con-
centrations in a cohort of patients with cholesterol and
pigment GS. Further in this study cohort, BMI values of
the patients with two types of GS were not significantly
different. Despite that serum TG and TC were high
among the patients with cholesterol GS compared to
that of pigment GS. Of these two parameters, serum TG
showed a significant difference as well. Further serum
TG and TC concentrations were high even in young pa-
tients with cholesterol GS compared to that of pigment
GS. This signifies the possible involvement of serum TG
and TC on the development of cholesterol GS even in
young patients. Moreover, none of the lipid parameters
were significantly different between females and males.
As the study was carried out among the patients with
GS disease with no prior diagnosis of dyslipidaemia, the
lipid parameters were normal in majority of patients.
Findings similar to the current study have been observed
among Indian patients with GS disease [22] and this
signifies the possibility of developing GS even in people
with normal lipid parameters. Detection of significantly
high serum TG in patients with cholesterol GS is ahe total study group
SD Males (n =13) Mean ± SD P value*
164.7 ± 21.6 0.374
147.9 ± 29.6 0.866
48.11 ± 9.64 0.065
87.0 ± 26.0 0.924
Table 5 Comparison of serum lipids in patients aged ≤ 50 years with two types of GS
Serum lipid parameter (mg/dl) Cholesterol GS (n = 31) Mean ± SD Pigment GS (n = 21) Mean ± SD P value*
TC 171.10 ± 32.0 165.1 ± 22.4 0.431
TG 153.50 ± 20.2 141.00 ± 30.7 0.108
HDL-C 54.86 ± 9.50 56.08 ± 9.34 0.650
LDL-C 85.50 ± 34.5 80.80 ± 26.2 0.581
*Two sample t test.
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risk factor of cholesterol GS [23]. High serum TG in
patients with GS is revealed in case control studies car-
ried out in countries with high prevalence of GS disease
as well [7-9]. The current finding further illustrates the
significant role of serum TG in the determination of
chemical composition of GS among the stone formers.
Hypertriglyceridemia is identified as a cause for gall blad-
der (GB) hypomotility as it reduces the GB sensitivity to
cholecystokinin [24], a paracrine hormone that regulates
the GB contraction. GB hypomotility is one of the main
causes for cholesterol crystallization [25]. Therefore the
negative effect of serum TG on GB motility can be consid-
ered as a cause to develop cholesterol GS than pigment
GS in people with high risk of GS disease.
The prevalence of GS depends on the gender where
females have a higher incidence [11]. Multiple reasons
have been evaluated in the identification of the cause for
this gender difference. However a possible effect of serum
lipids causing high incidence of GS among females was
not identified in this study. Interestingly female patients in
the study group had high serum HDL-C than that of male
patients. The favorable effects of female reproductive hor-
mones on serum lipids can be considered as a possible
reason for such observation, as mean age of females in the
study group was below the menopausal age which is
considered as 51 years for Sinhalese [20]. However, a
high risk of GS among patients with low HDL-C has
been observed [8].
In this study cohort, patients with pigment GS were sig-
nificantly older than those with cholesterol GS. In spite of
this, the serum lipid abnormalities were more common
among patients with cholesterol GS showing the possibil-
ities of developing cholesterol GS even in young patients
with impaired serum lipids. Importantly high serum TG
concentrations even at younger ages can be considered asTable 6 Comparison of serum lipids in patients aged > 50 yea
Serum lipid parameter (mg/dl) Cholesterol GS (n = 6) Mean
TC 176.94 ± 17.94
TG 162.70 ± 24.9
HDL-C 51.29 ± 7.16
LDL-C 93.12 ± 21.12
*Two sample t test.a risk factor to have cholesterol GS. Moreover, aging is
associated with significant changes in lipid profile and as
well as in the chemical composition of GS. High incidence
of pigment GS is observed in elderly population as cho-
lesterol content in GS gradually reduces with aging [12].
Similar changes in the GS composition were seen in pa-
tients in this study cohort as well. Though cholesterol GS
was significantly high among patients aged ≤ 50 years,
none of the lipid parameters were significantly different
between young (age ≤ 50 years) and elderly patients (age >
50 years) in the two types of GS. Though it was not statis-
tically significant, the results obtained for serum lipids for
cholesterol GS patients aged ≤ 50 years indicate a higher
tendency to have abnormal lipid profiles in their future
lives than that of pigment GS patients. Importantly the
lipid profile pattern seen among these patients should be
evaluated with caution as impaired lipid homeostasis is a
main risk factor for the cardiovascular disease as well [21].
Thus the development of GS disease can be considered as
a warning sign to have high risk of cardiovascular disease
for the patients with cholesterol GS. Increased mortality
due to cardiovascular disease among patients with GS in
USA has been observed [26].
In the current study patients with cholesterol GS
aged > 50 years had high serum HDL-C compared to that
of patients pigment GS and such finding was not observed
among the patients aged ≤ 50 years. However, the presence
of high serum TC and TG among cholesterol GS patients
in both age categories signifies the effect of serum TC and
TG on the formation of cholesterol GS over pigment GS
irrespective of the age.
Conclusion
Abnormal serum lipid profiles doesn’t seem to be an
essential feature in patients with cholesterol GS. However
when the two groups of patients with cholesterol andrs with two types of GS
± SD Pigment GS (n = 15) Mean ± SD P value*
171.57 ± 28.80 0.615
145.97 ± 21.76 0.188
45.13 ± 6.65 0.107
97.25 ± 30.98 0.731
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indexes were compared, patients with cholesterol GS are
more likely to have serum lipid parameters towards the
undesirable cutoff levels of their respective normal ranges.
However an effect of serum lipid concentrations on high
incidence of GS among females has not been identified.
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